Neues hämostatisches Pflaster ergänzt Ethicons umfassendes Biochirurgie-Portfolio und die Fähigkeit, wichtige ungedeckte Bedürfnisse bei der Kontrolle von Blutungen zu erfüllen RARITAN, New Jersey, 15. November 2023 /PRNewswire/ — Ethicon*, ein Johnson & Johnson MedTech-Unternehmen**,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.